BioLineRx and I-Bridge Capital launch drug development JV in China
BioLineRx, a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing new drugs, has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing new therapies. The joint venture, named iPharma, will develop clinical and pre-clinical therapeutic candidates originating primarily in Israel to